| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/06/2007 | US20070281005 Administering zonisamide; clearing mucus; protective patches |
| 12/06/2007 | US20070281000 Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof |
| 12/06/2007 | US20070280999 Orally administrable composition for the photoprotection of the skin |
| 12/06/2007 | US20070280997 Composition for enhancing muscle recovery |
| 12/06/2007 | US20070280996 Dietary supplement having improved efficacy at time of consumption |
| 12/06/2007 | US20070280995 Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye |
| 12/06/2007 | US20070280992 Sustained delivery formulations of rapamycin compounds |
| 12/06/2007 | US20070280991 Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug |
| 12/06/2007 | US20070280987 Bioactive polymers for imparting bioactive character to hydrophobic medical article surfaces |
| 12/06/2007 | US20070280980 Percutaneous Pharmaceutical Preparation for External Use Containing Nonsteroidal Antiinflammatory Analgesic |
| 12/06/2007 | US20070280979 Solid Oil-In-Water Emulsion |
| 12/06/2007 | US20070280972 Adhesive solid gel-forming formulations for dermal drug delivery |
| 12/06/2007 | US20070280971 Phosphodiesterase type IV (PDE4) inhibitor; 4-{[1-(aminocarbonyl)-4-piperidinyl]amino}-N-[(3,4-dimethylphenyl)methyl]-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide; inflammatory and/or allergic diseases such as atopic dermatitis |
| 12/06/2007 | US20070280970 Methods of Treating Wounds With Gonyautoxins |
| 12/06/2007 | US20070280963 Method for Producing Non-Pathogenic Helper Virus-Free Preparations of Herpes Virus Amplicon Vectors, the Helper Virus and the Cells Used in this Method, the Corresponding Generic Tools, as Well as the Applications of These Non-Pathogenic Amplicon Vectors |
| 12/06/2007 | US20070280961 cDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses and process for the production of such viruses |
| 12/06/2007 | US20070280944 Use of 5,10-Methylene Tetrahydrofolate for the Treatment of Cancer |
| 12/06/2007 | US20070280943 Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases |
| 12/06/2007 | US20070280939 Prostatic Acid Phosphatase Antigens |
| 12/06/2007 | US20070280930 Cd44-Targeting for Reducing/Preventing Ischemia-Reperfusion-Injury |
| 12/06/2007 | US20070280929 Adjuvant in the form of a lipid-modified nucleic acid |
| 12/06/2007 | US20070280928 Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors |
| 12/06/2007 | US20070280927 Treatment Of Neurodegenerative Diseases By The Use Of Atp7a |
| 12/06/2007 | US20070280926 Sting kit apparatus and method of use |
| 12/06/2007 | US20070280925 Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases |
| 12/06/2007 | US20070280924 Pharmaceutical Preparations For And Treatment Of Ocular Surface and Other Disorders |
| 12/06/2007 | US20070280918 Multitherapy Against Cancer |
| 12/06/2007 | US20070280917 Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment |
| 12/06/2007 | US20070280915 Combination Therapies Employing A Composition Comprising A Hmg Coa Reductase Inhibitor And A Vitamin B6 Related Compound |
| 12/06/2007 | US20070280913 biologically pure culture of Lactobacillus reuteri strain DSM 17938; promotes production of IL-10 and consequently proliferation of CD4+CD25+ TR cells; probiotic |
| 12/06/2007 | US20070280908 Treatment of diabetes with synthetic beta cells |
| 12/06/2007 | US20070280902 Method for treating eye disease or conditions affecting the posterior segment of the eye |
| 12/06/2007 | US20070280901 Method of inhibiting the transmission of influenza virus |
| 12/06/2007 | US20070280900 Compositions having a high antiviral efficacy |
| 12/06/2007 | US20070280899 Polyhydroxyalkanoates for In Vivo Applications |
| 12/06/2007 | US20070280890 System and method for disinfecting and drying a surface |
| 12/06/2007 | US20070280886 Diagnostics and Therapeutics for Diseases Associated with Adrenomedullin Receptor (Amdr) |
| 12/06/2007 | US20070280880 Method for cell-specific targeting |
| 12/06/2007 | US20070277393 Cabinet for automatic washing or/and drying machine and automatic washing or/and drying machine with the same |
| 12/06/2007 | DE102006026026A1 Arzneimittel Drug |
| 12/06/2007 | DE102006025319A1 Substituierte Heterozyklen und ihre Verwendung Substituted heterocycles and their use |
| 12/06/2007 | DE102006025318A1 Dihydro-pyrrolopyridin-, Dihydro-pyrrolopyridazin- und Dihydro-pyrrolopyrimidin-Derivate und ihre Verwendung Dihydro-pyrrolopyridin-, dihydro-pyrrolopyridazin- and dihydro-pyrrolopyrimidine derivatives and their use |
| 12/06/2007 | DE102006025317A1 Isoindolin-1-on-,Isoindolin-3-on und Isoindolin-1,3-dion-Derivate und ihre Verwendung Isoindoline-1-one, isoindoline-3-one and isoindoline-1,3-dione derivatives and their use |
| 12/06/2007 | DE102006025316A1 Isoindolin-1-on-, Isoindolin-3-on- und Isoindolin-1,3-dion-Derivate und ihre Verwendung Isoindoline-1-one, isoindoline-3-one and isoindoline-1,3-dione derivatives and their use |
| 12/06/2007 | DE102006025315A1 Tetrahydro-pyrrolopyridin-, Tetrahydro-pyrazolopyridin-, Tetrahydro-imidazopyridin- und Tetrahydro-triazolopyridin-Derivate und ihre Verwendung Tetrahydro-pyrrolopyridin-, tetrahydro-pyrazolopyridin-, tetrahydro-imidazopyridine and tetrahydro-triazolopyridine derivatives and their use |
| 12/06/2007 | DE102006025314A1 Arylsubstituierte Heterozyklen und ihre Verwendung Aryl-substituted heterocycles and their use |
| 12/06/2007 | CA2689445A1 Fucoidan compositions and methods |
| 12/06/2007 | CA2688028A1 Improved tissue maintenance |
| 12/06/2007 | CA2659570A1 3-(1,3-benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-1-yl)-pyridazine, itssalts and solvates and its use as histamine h3 receptor antagonist |
| 12/06/2007 | CA2655668A1 Aziridinyl-epothilone compounds |
| 12/06/2007 | CA2655140A1 Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses |
| 12/06/2007 | CA2654402A1 Multiple unit pharmaceutical formulation |
| 12/06/2007 | CA2654281A1 Use of phytate as agent inhibiting dissolution of crystals of calcium salts for the prevention of osteoporosis |
| 12/06/2007 | CA2654276A1 Pharmaceutical composition for treatment of viral infections and/or tumor diseases by inhibiting protein folding and protein degradation |
| 12/06/2007 | CA2654270A1 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia |
| 12/06/2007 | CA2653956A1 New crystal forms |
| 12/06/2007 | CA2653939A1 Immunostimulatory oligonucleotides and use thereof in pharmaceuticals |
| 12/06/2007 | CA2653933A1 Anti-foot-and-mouth disease virus agent for animal belonging to family suidae or sheep, and method for prevention or treatment of foot-and-mouth disease in animal belonging to family suidae or sheep |
| 12/06/2007 | CA2653925A1 Combination of amino acid solution and a gelatin derivative for inhibiting renal uptake |
| 12/06/2007 | CA2653924A1 Biphenyl derivatives and their use in treating hepatitis c |
| 12/06/2007 | CA2653920A1 Composition for controlling snoring, in the form of a nasal spray |
| 12/06/2007 | CA2653916A1 Nasal and buccal compositions for controlling snoring |
| 12/06/2007 | CA2653902A1 Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye |
| 12/06/2007 | CA2653872A1 Novel heterocyclic compounds |
| 12/06/2007 | CA2653840A1 Method and compound for the treatment of valvular disease |
| 12/06/2007 | CA2653835A1 New use for cannabinoid |
| 12/06/2007 | CA2653818A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
| 12/06/2007 | CA2653805A1 Intestinal eosinophil-suppressing composition |
| 12/06/2007 | CA2653771A1 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands |
| 12/06/2007 | CA2653770A1 Combination of chemotherapeutic compounds for treating cancer |
| 12/06/2007 | CA2653769A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
| 12/06/2007 | CA2653744A1 Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists |
| 12/06/2007 | CA2653681A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives and their medical use |
| 12/06/2007 | CA2653675A1 Tetrahydropyrrolopyridine, tetrahydropyrazolopyridine, tetrahydroimidazopyridine and tetrahydrotriazolopyridine derivatives and their use |
| 12/06/2007 | CA2653672A1 Dihydro-pyrrolopyridine, dihydro-pyrrolopyridazine and dihydro-pyrrolopyrimidine derivatives and their use |
| 12/06/2007 | CA2653670A1 Substituted heterocycles and their use |
| 12/06/2007 | CA2653667A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 12/06/2007 | CA2653665A1 Isoindolin-1-one, isoindolin-3-one and isoindoline-1,3-dione-derivatives and their use |
| 12/06/2007 | CA2653662A1 Spirocyclic nitriles as protease inhibitors |
| 12/06/2007 | CA2653660A1 Sulphated hyaluronic acid for treating degenerative osteoarthritis |
| 12/06/2007 | CA2653506A1 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
| 12/06/2007 | CA2653497A1 Heterocyclic compounds as calcium channel blockers |
| 12/06/2007 | CA2653472A1 Novel lapachone compounds and methods of use thereof |
| 12/06/2007 | CA2653460A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use |
| 12/06/2007 | CA2653412A1 4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them |
| 12/06/2007 | CA2653403A1 Lipoic acid pellets |
| 12/06/2007 | CA2653371A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use |
| 12/06/2007 | CA2653336A1 Method for treating non-hodgkin's lymphoma |
| 12/06/2007 | CA2653334A1 5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin and its preparation and use for the treatment of cancer |
| 12/06/2007 | CA2653332A1 Triazole compounds that modulate hsp90 activity |
| 12/06/2007 | CA2653329A1 Triazole compounds that modulate hsp90 activity |
| 12/06/2007 | CA2653319A1 Hsp90 inhibitor |
| 12/06/2007 | CA2653313A1 Administration of the reg1 anticoagulation system |
| 12/06/2007 | CA2653298A1 Crystalline form of 5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin |
| 12/06/2007 | CA2653288A1 Methods of modulating epithelial-mesenchymal transition and mesenchymal-epithelial transition in cells and agents useful for the same |
| 12/06/2007 | CA2653262A1 Preparation and utility of substituted carboxylic acid compounds |
| 12/06/2007 | CA2653223A1 Therapeutic pyrrolidine compounds |
| 12/06/2007 | CA2653222A1 Triazole compounds that modulate hsp90 activity |
| 12/06/2007 | CA2653217A1 Method for treating proliferative disorders associated with protooncogene products |
| 12/06/2007 | CA2653209A1 Deuterated aminoglycidyl compounds |